demonstrated that during EMT, the expression of CD44 shifts from variant isoforms (CD44v) to standard isoforms (CD44s), and the regulation of CD44 selective splicing leads to EMT and breast cancer progression (101). This evidence concerns the gene CD44 and breast cancer.